Catalyst Wire Dossier Catalyst Wire Dossier

Wegovy (semaglutide)

semaglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Wegovy (semaglutide), covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity [Phase 4]

See pricing